- Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy
[作者：Arvold, ND; Taghian, AG; Niemierko, A; Raad, RFA; Sreedhara, M; Nguyen, PL; Bellon, JR; Wong, JS; Smith, BL; Harris, JR,期刊：Journal of clinical oncology, 页码：3885-3891 , 文章类型： Article，,卷期：2011年29-29]
- Purpose Prior results of breast-conserving therapy (BCT) have shown substantial rates of local recurrence (LR) in young patients with breast cancer (BC). Patients and Methods We studied 1,434 consecutive patients with in...
- American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women With Early-Stage Invasive Breast Cancer
[作者：Griggs, JJ; Somerfield, MR; Anderson, H; Henry, NL; Hudis, CA; Khatcheressian, JL; Partridge, AH; Prestrud, AA; Davidson, NE,期刊：Journal of clinical oncology, 页码：3939-3942 , 文章类型： Article，,卷期：2011年29-29]
- Purpose The American Society of Clinical Oncology (ASCO) has policies and procedures for endorsing practice guidelines that have been developed by other professional organizations. Methods The Cancer Care Ontario (CCO) G...
- Completion of Adjuvant Chemotherapy and Use of Health Services for Older Women With Epithelial Ovarian Cancer
[作者：Fairfield, KM; Murray, K; Lucas, FL; Wierman, HR; Earle, CC; Trimble, EL; Small, L; Warren, JL,期刊：Journal of clinical oncology, 页码：3921-3926 , 文章类型： Article，,卷期：2011年29-29]
- Purpose This analysis identifies factors associated with completion of adjuvant chemotherapy for patients with ovarian cancer and subsequent use of health services. Patients and Methods We used the Surveillance, Epidemio...
- Clinical and Prognostic Implications of Plasma Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Patients With Hepatocellular Carcinoma
[作者：Kaseb, AO; Morris, JS; Hassan, MM; Siddiqui, AM; Lin, E; Xiao, LC; Abdalla, EK; Vauthey, JN; Aloia, TA; Krishnan, S; Abbruzzese, JL,期刊：Journal of clinical oncology, 页码：3892-3899 , 文章类型： Article，,卷期：2011年29-29]
- Purpose Cirrhosis and hepatocellular carcinoma (HCC) together form a two-disease state that affects survival of patients with HCC and dictates treatment decisions and prognostic stratification of patients in clinical tri...
- FSTL5 Is a Marker of Poor Prognosis in Non-WNT/Non-SHH Medulloblastoma
[作者：Remke, M; Hielscher, T; Korshunov, A; Northcott, PA; Bender, S; Kool, M; Westermann, F; Benner, A; Cin, H; Ryzhova, M; Sturm, D; Witt, H; Haag, D; Toedt, G; Wittmann, A; Schottler, A; von Bueren, AO; von Deimling, A; Rutkowski, S; Scheurlen, W; Kulozik, AE; Taylor, MD; Lichter, P; Pfister, SM,期刊：Journal of clinical oncology, 页码：3852-3861 , 文章类型： Article，,卷期：2011年29-29]
- Purpose Integrated genomics approaches have revealed at least four distinct biologic variants of medulloblastoma: WNT (wingless), SHH (sonic hedgehog), group C, and group D. Because of the remarkable clinical heterogenei...
- Management of Hot Flashes in Patients Who Have Breast Cancer With Venlafaxine and Clonidine: A Randomized, Double-Blind, Placebo-Controlled Trial
[作者：Boekhout, AH; Vincent, AD; Dalesio, OB; van den Bosch, J; Foekema-Tons, JH; Adriaansz, S; Sprangers, S; Nuijen, B; Beijnen, JH; Schellens, JHM,期刊：Journal of clinical oncology, 页码：3862-3868 , 文章类型： Article，,卷期：2011年29-29]
- Purpose Therapies for breast cancer may induce hot flashes that can affect quality of life. We undertook a double-blind, placebo-controlled trial with the primary objective of comparing the average daily hot flash scores...
|